These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2117172)

  • 1. Mucolytics: when dispensable, when necessary?
    Dorow P
    Lung; 1990; 168 Suppl():622-6. PubMed ID: 2117172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol Medications for Treatment of Mucus Clearance Disorders.
    Rubin BK
    Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.
    Gallon AM
    Thorax; 1996 Apr; 51(4):429-32. PubMed ID: 8733499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
    Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
    Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
    Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Expectoration and inhalation therapy].
    Nakamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Nov; 28(11):1421-5. PubMed ID: 2290225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expectoration disorders in patients with chronic obstructive lung diseases].
    Solopov VN; Lunichkina IV
    Klin Med (Mosk); 1990 May; 68(5):60-5. PubMed ID: 2398723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Chong J; Cates CJ
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
    Dal Negro R; Pozzi E; Cella SG
    Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
    Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
    Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mucus in cough research.
    Rubin BK
    Lung; 2010 Jan; 188 Suppl 1():S69-72. PubMed ID: 19936981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of the National Mucolytic Study.
    Morgan EJ; Petty TL
    Chest; 1990 Feb; 97(2 Suppl):24S-27S. PubMed ID: 2404710
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases.
    Arenhoevel J; Kuppe A; Addante A; Wei LF; Boback N; Butnarasu C; Zhong Y; Wong C; Graeber SY; Duerr J; Gradzielski M; Lauster D; Mall MA; Haag R
    Biomater Sci; 2024 Aug; 12(17):4376-4385. PubMed ID: 39028033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
    Nash EF; Stephenson A; Ratjen F; Tullis E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007168. PubMed ID: 19160327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.